{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:59:17Z","timestamp":1788051557909,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.neuropharm.2013.06.026","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T01:31:11Z","timestamp":1373333471000},"page":"53-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Synergistic effect of 5-HT1A and \u03c31 receptor activation on prefrontal dopaminergic transmission under circulating steroid deficiency"],"prefix":"10.1016","volume":"75","author":[{"given":"Naoki","family":"Hiramatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Takuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.06.026_bib53","doi-asserted-by":"crossref","first-page":"14602","DOI":"10.1073\/pnas.0606544103","article-title":"Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis","volume":"103","author":"Ag\u00eds-Balboa","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0028-3908(03)00304-6","article-title":"Regulation by 5-HT1A receptors of the in\u00a0vivo release of 5-HT and DA in mouse frontal cortex","volume":"45","author":"Ago","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pbb.2006.07.036","article-title":"Effects of osemozotan, ritanserin and azasetron on cocaine-induced behavioral sensitization in mice","volume":"85","author":"Ago","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/syn.20421","article-title":"Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice","volume":"61","author":"Ago","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib4","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.neuropharm.2006.06.001","article-title":"Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice","volume":"51","author":"Ago","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00213-011-2293-5","article-title":"Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized\/castrated mice via both 5-HT reuptake inhibition and \u03c31 receptor activation","volume":"217","author":"Ago","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00165384","article-title":"The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons","volume":"347","author":"Arborelius","year":"1993","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/cercor\/bhq083","article-title":"Gonadectomy and hormone replacement affects in\u00a0vivo basal extracellular dopamine levels in the prefrontal cortex but not motor cortex of adult male rats","volume":"21","author":"Aubele","year":"2011","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib9","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1046\/j.1471-4159.1995.64041585.x","article-title":"Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (\u00b1)-8-hydroxy-2-(di-n-propylamino)tetralin","volume":"64","author":"Chen","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma1 receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endo.133.3.8365352","article-title":"Neurosteroids: 3\u03b1-hydroxy-5\u03b1-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats","volume":"133","author":"Corp\u00e9chot","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1471-4159.2002.01218.x","article-title":"Progesterone enhances ethanol-induced modulation of mesocortical dopamine neurons: antagonism by finasteride","volume":"83","author":"Dazzi","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(02)02290-4","article-title":"Depletion of cortical allopregnanolone potentiates stress-induced increase in cortical dopamine output","volume":"932","author":"Dazzi","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.neuropharm.2007.07.009","article-title":"Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice","volume":"53","author":"Fox","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib15","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0006-3223(94)91139-8","article-title":"CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI","volume":"35","author":"George","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0006-8993(96)01394-7","article-title":"Androgen inhibits neurotransmitter turnover in the medial prefrontal cortex of the rat following exposure to a novel environment","volume":"751","author":"Handa","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.npp.1301047","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors","volume":"32","author":"Hashimoto","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14728222.12.1.45","article-title":"An update on the development of drugs for neuropsychiatric disorders: focusing on the \u03c31 receptor ligand","volume":"12","author":"Hayashi","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00023210-200418050-00001","article-title":"\u03c3-1 receptor ligands: potential in the treatment of neuropsychiatric disorders","volume":"18","author":"Hayashi","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/WNR.0b013e328352de40","article-title":"5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux","volume":"23","author":"Huang","year":"2012","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0022-3565(25)20943-0","article-title":"Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the rat brain","volume":"279","author":"Kobayashi","year":"1996","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1471-4159.2010.06750.x","article-title":"Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice","volume":"114","author":"Koda","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib24","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1210\/en.2005-0955","article-title":"Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry","volume":"147","author":"Labombarda","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib25","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0022-3565(24)36532-2","article-title":"Interactions of (+)- and (\u2013)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats","volume":"280","author":"Lejeune","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuroscience.2011.06.076","article-title":"Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence","volume":"191","author":"Marx","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300015","article-title":"Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents","volume":"28","author":"Marx","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-3565(25)38212-1","article-title":"Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex","volume":"265","author":"Matsuno","year":"1993","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0006-8993(95)00618-Z","article-title":"Involvement of sigma 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats","volume":"690","author":"Matsuno","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-0173(01)00112-6","article-title":"The interaction between neuroactive steroids and the \u03c31 receptor function: behavioral consequences and therapeutic opportunities","volume":"37","author":"Maurice","year":"2001","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.06.024","article-title":"Neuroactive steroids: focus on human brain","volume":"191","author":"Melcangi","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1043-2760(01)00503-3","article-title":"Neurosteroids: biochemistry and clinical significance","volume":"13","author":"Mellon","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/syn.20254","article-title":"The acute and chronic administration of (\u00b1)-8-hydroxy-2-(di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in\u00a0vivo electrophysiological study","volume":"59","author":"Nakamura","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(96)00254-3","article-title":"Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain","volume":"307","author":"Narita","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib34","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"1996"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2174\/138161212799436476","article-title":"Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases","volume":"18","author":"Niitsu","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1210\/jcem-59-3-551","article-title":"Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood","volume":"59","author":"Orentreich","year":"1984","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib37","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1046\/j.1460-9568.1999.00656.x","article-title":"Modulation of steroidal levels by adrenalectomy\/castration and inhibition of neurosteroid synthesis enzymes affect \u03c31 receptor-mediated behaviour in mice","volume":"11","author":"Phan","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s002130050663","article-title":"Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test","volume":"138","author":"Redrobe","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s002130100836","article-title":"Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?","volume":"159","author":"Renard","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-3223(98)00328-X","article-title":"Concentrations of 3\u03b1-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery","volume":"45","author":"Str\u00f6hle","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-3956(00)00006-6","article-title":"Fluoxetine decreases concentrations of 3\u03b1,5\u03b1-tetrahydrodeoxycorticosterone (THDOC) in major depression","volume":"34","author":"Str\u00f6hle","year":"2000","journal-title":"J.\u00a0Psychiat. Res."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib43","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s12031-012-9861-y","article-title":"Serotonin 5-HT7 receptor blockade reverses behavioral abnormalities in PACAP-deficient mice and receptor activation promotes neurite extension in primary embryonic hippocampal neurons: therapeutic implications for psychiatric disorders","volume":"48","author":"Tajiri","year":"2012","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib44","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(24)29502-1","article-title":"The antidepressant-like effect induced by \u03c31-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test","volume":"298","author":"Urani","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00213-002-1150-y","article-title":"The antidepressant-like effect induced by the sigma1 (\u03c31) receptor agonist igmesine involves modulation of intracellular calcium mobilization","volume":"163","author":"Urani","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-002-1257-1","article-title":"Neurosteroids in depression: a review","volume":"165","author":"van Broekhoven","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib47","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1523\/JNEUROSCI.19-15-06684.1999","article-title":"Independent and overlapping effects of corticosterone and testosterone on corticotropin-releasing hormone and arginine vasopressin mRNA expression in the paraventricular nucleus of the hypothalamus and stress-induced adrenocorticotropic hormone release","volume":"19","author":"Viau","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib48","first-page":"464","article-title":"Influence of serotonin 5-HT7 receptor blockade on the behavioral and neurochemical effects of imipramine in rats","volume":"60","author":"Weso\u0142owska","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2013.06.026_bib49","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.156.4.646","article-title":"Double-blind treatment of major depression with dehydroepiandrosterone","volume":"156","author":"Wolkowitz","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-3223(96)00043-1","article-title":"Dehydroepiandrosterone (DHEA) treatment of depression","volume":"41","author":"Wolkowitz","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib51","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1210\/en.2011-1218","article-title":"Minireview: stress-related psychiatric disorders with low cortisol levels: a metabolic hypothesis","volume":"152","author":"Yehuda","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2013.06.026_bib52","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pneurobio.2009.07.001","article-title":"Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance","volume":"89","author":"Zheng","year":"2009","journal-title":"Prog. Neurobiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:42:32Z","timestamp":1758436952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813002955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":53,"alternative-id":["S0028390813002955"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.026","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effect of 5-HT1A and \u03c31 receptor activation on prefrontal dopaminergic transmission under circulating steroid deficiency","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}